131 related articles for article (PubMed ID: 32387251)
1. Discovery and characterization of a monogenetic insult, caveolin-3-V37L, that precipitated oligo-proteomic perturbations governing repolarization reserve.
Ye D; Zhou W; Tester DJ; Ackerman MJ
Int J Cardiol; 2020 Nov; 319():71-77. PubMed ID: 32387251
[TBL] [Abstract][Full Text] [Related]
2. Long QT syndrome caveolin-3 mutations differentially modulate K
Tyan L; Foell JD; Vincent KP; Woon MT; Mesquitta WT; Lang D; Best JM; Ackerman MJ; McCulloch AD; Glukhov AV; Balijepalli RC; Kamp TJ
J Physiol; 2019 Mar; 597(6):1531-1551. PubMed ID: 30588629
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the CACNA1C-R518C Missense Mutation in the Pathobiology of Long-QT Syndrome Using Human Induced Pluripotent Stem Cell Cardiomyocytes Shows Action Potential Prolongation and L-Type Calcium Channel Perturbation.
Estes SI; Ye D; Zhou W; Dotzler SM; Tester DJ; Bos JM; Kim CSJ; Ackerman MJ
Circ Genom Precis Med; 2019 Aug; 12(8):e002534. PubMed ID: 31430211
[TBL] [Abstract][Full Text] [Related]
4. Mutant caveolin-3 induces persistent late sodium current and is associated with long-QT syndrome.
Vatta M; Ackerman MJ; Ye B; Makielski JC; Ughanze EE; Taylor EW; Tester DJ; Balijepalli RC; Foell JD; Li Z; Kamp TJ; Towbin JA
Circulation; 2006 Nov; 114(20):2104-12. PubMed ID: 17060380
[TBL] [Abstract][Full Text] [Related]
5. Caveolin-3 and Caveolae regulate ventricular repolarization.
Markandeya YS; Gregorich ZR; Feng L; Ramchandran V; O' Hara T; Vaidyanathan R; Mansfield C; Keefe AM; Beglinger CJ; Best JM; Kalscheur MM; Lea MR; Hacker TA; Gorelik J; Trayanova NA; Eckhardt LL; Makielski JC; Balijepalli RC; Kamp TJ
J Mol Cell Cardiol; 2023 Apr; 177():38-49. PubMed ID: 36842733
[TBL] [Abstract][Full Text] [Related]
6. Caveolin-3 suppresses late sodium current by inhibiting nNOS-dependent S-nitrosylation of SCN5A.
Cheng J; Valdivia CR; Vaidyanathan R; Balijepalli RC; Ackerman MJ; Makielski JC
J Mol Cell Cardiol; 2013 Aug; 61():102-10. PubMed ID: 23541953
[TBL] [Abstract][Full Text] [Related]
7. The role of CAV3 in long-QT syndrome: clinical and functional assessment of a caveolin-3/Kv11.1 double heterozygote versus caveolin-3 single heterozygote.
Hedley PL; Kanters JK; Dembic M; Jespersen T; Skibsbye L; Aidt FH; Eschen O; Graff C; Behr ER; Schlamowitz S; Corfield V; McKenna WJ; Christiansen M
Circ Cardiovasc Genet; 2013 Oct; 6(5):452-61. PubMed ID: 24021552
[TBL] [Abstract][Full Text] [Related]
8. The interaction of caveolin 3 protein with the potassium inward rectifier channel Kir2.1: physiology and pathology related to long qt syndrome 9 (LQT9).
Vaidyanathan R; Vega AL; Song C; Zhou Q; Tan BH; Berger S; Makielski JC; Eckhardt LL
J Biol Chem; 2013 Jun; 288(24):17472-80. PubMed ID: 23640888
[TBL] [Abstract][Full Text] [Related]
9. Modeling type 3 long QT syndrome with cardiomyocytes derived from patient-specific induced pluripotent stem cells.
Ma D; Wei H; Zhao Y; Lu J; Li G; Sahib NB; Tan TH; Wong KY; Shim W; Wong P; Cook SA; Liew R
Int J Cardiol; 2013 Oct; 168(6):5277-86. PubMed ID: 23998552
[TBL] [Abstract][Full Text] [Related]
10. Caveolin-3 Microdomain: Arrhythmia Implications for Potassium Inward Rectifier and Cardiac Sodium Channel.
Vaidyanathan R; Reilly L; Eckhardt LL
Front Physiol; 2018; 9():1548. PubMed ID: 30473666
[TBL] [Abstract][Full Text] [Related]
11. Genome Editing of Induced Pluripotent Stem Cells to Decipher Cardiac Channelopathy Variant.
Garg P; Oikonomopoulos A; Chen H; Li Y; Lam CK; Sallam K; Perez M; Lux RL; Sanguinetti MC; Wu JC
J Am Coll Cardiol; 2018 Jul; 72(1):62-75. PubMed ID: 29957233
[TBL] [Abstract][Full Text] [Related]
12. Novel mechanism for sudden infant death syndrome: persistent late sodium current secondary to mutations in caveolin-3.
Cronk LB; Ye B; Kaku T; Tester DJ; Vatta M; Makielski JC; Ackerman MJ
Heart Rhythm; 2007 Feb; 4(2):161-6. PubMed ID: 17275750
[TBL] [Abstract][Full Text] [Related]
13. Phenotypic variability in LQT3 human induced pluripotent stem cell-derived cardiomyocytes and their response to antiarrhythmic pharmacologic therapy: An in silico approach.
Paci M; Passini E; Severi S; Hyttinen J; Rodriguez B
Heart Rhythm; 2017 Nov; 14(11):1704-1712. PubMed ID: 28756098
[TBL] [Abstract][Full Text] [Related]
14. Patient-independent human induced pluripotent stem cell model: A new tool for rapid determination of genetic variant pathogenicity in long QT syndrome.
Chavali NV; Kryshtal DO; Parikh SS; Wang L; Glazer AM; Blackwell DJ; Kroncke BM; Shoemaker MB; Knollmann BC
Heart Rhythm; 2019 Nov; 16(11):1686-1695. PubMed ID: 31004778
[TBL] [Abstract][Full Text] [Related]
15. Human Induced Pluripotent Stem Cell-Derived Engineered Heart Tissue as a Sensitive Test System for QT Prolongation and Arrhythmic Triggers.
Lemoine MD; Krause T; Koivumäki JT; Prondzynski M; Schulze ML; Girdauskas E; Willems S; Hansen A; Eschenhagen T; Christ T
Circ Arrhythm Electrophysiol; 2018 Jul; 11(7):e006035. PubMed ID: 29925535
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of nefazodone-induced cardiotoxicity in human induced pluripotent stem cell-derived cardiomyocytes.
Lee S; Lee HA; Choi SW; Kim SJ; Kim KS
Toxicol Appl Pharmacol; 2016 Apr; 296():42-53. PubMed ID: 26821276
[TBL] [Abstract][Full Text] [Related]
17. Large-Scale Simulation of the Phenotypical Variability Induced by Loss-of-Function Long QT Mutations in Human Induced Pluripotent Stem Cell Cardiomyocytes.
Paci M; Casini S; Bellin M; Hyttinen J; Severi S
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30428582
[TBL] [Abstract][Full Text] [Related]
18. Repolarization instability and arrhythmia by IKr block in single human-induced pluripotent stem cell-derived cardiomyocytes and 2D monolayers.
Altrocchi C; de Korte T; Bernardi J; Spätjens RLHMG; Braam SR; Heijman J; Zaza A; Volders PGA
Europace; 2020 Sep; 22(9):1431-1441. PubMed ID: 32770183
[TBL] [Abstract][Full Text] [Related]
19. Drug-Mediated Shortening of Action Potentials in LQTS2 Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
Duncan G; Firth K; George V; Hoang MD; Staniforth A; Smith G; Denning C
Stem Cells Dev; 2017 Dec; 26(23):1695-1705. PubMed ID: 28992755
[TBL] [Abstract][Full Text] [Related]
20. Tbx5 variants disrupt Nav1.5 function differently in patients diagnosed with Brugada or Long QT Syndrome.
Nieto-Marín P; Tinaquero D; Utrilla RG; Cebrián J; González-Guerra A; Crespo-García T; Cámara-Checa A; Rubio-Alarcón M; Dago M; Alfayate S; Filgueiras-Rama D; Peinado R; López-Sendón JL; Jalife J; Tamargo J; Bernal JA; Caballero R; Delpón E;
Cardiovasc Res; 2022 Mar; 118(4):1046-1060. PubMed ID: 33576403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
